Due to the complexity of blood glucose dynamics and the high variability of the physiological structure of diabetic patients, implementing a safe and effective insulin dosage control algorithm to keep the blood glucose of diabetic patients within the normal range (70-180 mg/dL) is currently a challenging task in the field of diabetes treatment. This evidence concerns the gene INS and diabetes mellitus.